Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model

Tissue Engineering - Part A

Volumn 15, Issue 9, 2009, Pages 2347-2362

  Young, Simon ^a   Patel, Zarana S ^a   Kretlow, James D ^a   Murphy, Matthew B ^a   Mountziaris, Paschalia M ^a   Baggett, L Scott ^a   Ueda, Hiroki ^b   Tabata, Yasuhiko ^c   Jansen, John A ^d   Wong, Mark ^e   Mikos, Antonios G ^a  

^a Rice University   (United States)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; COMPUTERIZED TOMOGRAPHY; DEFECTS; DRUG PRODUCTS; PEPTIDES; SELF ASSEMBLY; TOMOGRAPHY;

BONE FORMATION; BONE MORPHOGENETIC PROTEIN-2; BONE REGENERATION; BURST RELEASE; DEFECT MODEL; DOSE EFFECTS; DOSE-DEPENDENT; IN-VITRO; IN-VIVO; MICROCOMPUTED TOMOGRAPHY; RELEASE RATE; SUSTAINED RELEASE; VASCULAR ENDOTHELIAL GROWTH FACTOR;

BONE;

BONE MORPHOGENETIC PROTEIN 2; GELATIN; POLYETHYLENE DERIVATIVE; POLYETHYLENE FUMARIC ACID; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE REGENERATION; COMPOSITE MATERIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; HISTOLOGY; MALE; NONHUMAN; OSSIFICATION; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SKULL DEFECT; SUSTAINED DRUG RELEASE;

RATTUS;

EID: 69249088910     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0510     Document Type: Article

References (64)

1. Geiger, M., Li, R.H., and Friess, W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 55, 1613, 2003.
2. Silva, R.M., Elvira, C., Mano, J.F., San Roman, J., and Reis, R.L. Influence of beta-radiation sterilisation in properties of new chitosan/soybean protein isolate membranes for guided bone regeneration. J Mater Sci Mater Med 15, 523, 2004.
3. Takahashi, Y., Yamamoto, M., Yamada, K., Kawakami, O., and Tabata, Y. Skull bone regeneration in nonhuman primates by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 13, 293, 2007.
4. Shi, X., Sitharaman, B., Pham, Q.P., Liang, F., Wu, K., Billups, W.E., Wilson, L.J., and Mikos, A.G. Fabrication of porous ultra-short single-walled carbon nanotube nanocomposite scaffolds for bone tissue engineering. Biomaterials 28, 4078, 2007.
5. Shea, L.D., Wang, D., Franceschi, R.T., and Mooney, D.J. Engineered bone development from a pre-osteoblast cell line on three-dimensional scaffolds. Tissue Eng 6, 605, 2000.
6. Rai, B., Ho, K.H., Lei, Y., Si-Hoe, K.M., Teo, J., C.M., Yacob, K.B., Chen, F., Ng, F.C., and Teoh, S.H. Polycaprolactone20% tricalcium phosphate scaffolds in combination with platelet-rich plasma for the treatment of critical-sized defects of the mandible: a pilot study. J Oral Maxillofac Surg 65, 2195, 2007.
7. Spoerke, E.D., Murray, N.G., Li, H., Brinson, L.C., Durand, D.C., and Stupp, S.I. Titanium with aligned, elongated pores for orthopedic tissue engineering applications. J Biomed Mater Res A 84, 402, 2008.
8. Datta, N., Pham, Q.P., Sharma, U., Sikavitsas, V.I., Jansen, J.A., and Mikos, A.G. In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation. Proc Natl Acad Sci USA 103, 2488, 2006.
9. Leach, J.K., Kaigler, D., Wang, Z., Krebsbach, P.H., and Mooney, D.J. Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials 27, 3249, 2006.
10. Ruhe, P.Q., Hedberg, E.L., Padron, N.T., Spauwen, P.H., Jansen, J.A., and Mikos, A.G. Biocompatibility and degradation of poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composites. J Biomed Mater Res A 74, 533, 2005.
11. Khan, Y.M., Katti, D.S., and Laurencin, C.T. Novel polymersynthesized ceramic composite-based system for bone repair: an in vitro evaluation. J Biomed Mater Res A 69, 728, 2004.
12. McKay, W.F., Peckham, S.M., and Badura, J.M. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE((R)) Bone Graft). Int Orthop 31, 729, 2007.
13. Iwakura, A., Tabata, Y., Koyama, T., Doi, K., Nishimura, K., Kataoka, K., Fujita, M., and Komeda, M. Gelatin sheet incorporating basic fibroblast growth factor enhances sternal healing after harvesting bilateral internal thoracic arteries. J Thorac Cardiovasc Surg 126, 1113, 2003.
14. Nevins, M., Camelo, M., Nevins, M.L., Schenk, R.K., and Lynch, S.E. Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone. J Periodontol 74, 1282, 2003.
15. Wang, Y., Wan, C., Szoke, G., Ryaby, J.T., and Li, G. Local injection of thrombin-related peptide (TP508) in PPF/PLGA microparticles-enhanced bone formation during distraction osteogenesis. J Orthop Res 26, 539, 2008.
16. Dean, D., Wolfe, M.S., Ahmad, Y., Totonchi, A., Chen, J.E., Fisher, J.P., Cooke, M.N., Rimnac, C.M., Lennon, D.P., Caplan, A.I., Topham, N.S., and Mikos, A.G. Effect of transforming growth factor beta2 on marrow-infused foam polypropylene fumarate) tissue-engineered constructs for the repair of critical-size cranial defects in rabbits. Tissue Eng 11, 923,2005.
17. Kaigler, D., Wang, Z., Horger, K., Mooney, DJ., and Krebsbach, P.H. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res 21, 735, 2006.
18. Gimbel, M., Ashley, R.K., Sisodia, M., Gabbay, J.S., Wasson, K.L., Heller, J., Wilson, L., Kawamoto, H.K., and Bradley, J.P. Repair of alveolar cleft defects: reduced morbidity with bone marrow stem cells in a resorbable matrix. J Craniofac Surg 18, 895, 2007.
19. Usas, A., and Huard, J. Muscle-derived stem cells for tissue engineering and regenerative therapy. Biomaterials 28, 5401, 2007.
20. Peterson, B., Zhang, J., Iglesias, R., Kabo, M., Hedrick, M., Benhaim, P., and Lieberman, J.R. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng 11, 120, 2005.
21. Colton, C.K. Implantable biohybrid artificial organs. Cell Transplant 4, 415, 1995.
22. Goldstein, A.S., Juarez, T.M., Helmke, C.D., Gustin, M.C., and Mikos, A.G. Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds. Biomaterials 22, 1279, 2001.
23. Folkman, J., and Hochberg, M. Self-regulation of growth in three dimensions. J Exp Med 138, 745, 1973.
24. Thompson, T.J., Owens, P.D., and Wilson, D.J. Intramembranous osteogenesis and angiogenesis in the chick embryo. J Anat 166, 55, 1989.
25. Maes, C., Carmeliet, P., Moermans, K., Stockmans, I., Smets, N., Collen, D., Bouillon, R., and Carmeliet, G. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech Dev 111, 61, 2002.
26. Geris, L., Gerisch, A., Sloten, J.V., Weiner, R., and Oosterwyck, H.V. Angiogenesis in bone fracture healing: a bioregulatory model. J Theor Biol 251, 137, 2008.
27. Axelrad, T.W., Kakar, S., and Einhorn, T.A. New technologies for the enhancement of skeletal repair. Injury 38 Suppl 1, S49, 2007.
28. Hirschi, K.K., Skalak, T.C., Peirce, S.M., and Little, C.D. Vascular assembly in natural and engineered tissues. Ann NY Acad Sci 961, 223, 2002.
29. Ribatti, D. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review. Br J Haematol 128, 303, 2005.
30. Deckers, M.M., Karperien, M., van der Bent, C., Yamashita, T., Papapoulos, S.E., and Lowik, C.W. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 141, 1667, 2000.
31. Li, G., Cui, Y., McIlmurray, L., Allen, W.E., and Wang, H. rhBMP-2, rhVEGF(165), rhPTN and thrombin-related peptide, TP508 induce Chemotaxis of human osteoblasts and microvascular endothelial cells. J Orthop Res 23, 680, 2005.
32. Street, J., Bao, M., deGuzman, L., Bunting, S., Peale, F.V., Jr., Ferrara, N., Steinmetz, H., Hoeffel, J., Cleland, J.L., Daugherty, A., van Bruggen, N., Redmond, H.P., Carano, R.A., and Filvaroff, E.H. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99, 9656, 2002.
33. Sipola, A., Ilvesaro, J., Birr, E., Jalovaara, P., Pettersson, R.F., Stenback, F., Yla-Herttuala, S., Hautala, T., and Tuukkanen, J. Endostatin inhibits endochondral ossification. J Gene Med 9, 1057, 2007.
34. Peng, H., Usas, A., Olshanski, A., Ho, A.M., Gearhart, B., Cooper, G.M., and Huard, J. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20, 2017, 2005.
35. Bouletreau, PJ., Warren, S.M., Specter, J.A., Peled, Z.M., Gerrets, R.P., Greenwald, J.A., and Longaker, M.T. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast Reconstr Surg 109, 2384, 2002.
36. Deckers, M.M., van Bezooijen, R.L., van der Horst, G., Hoogendam, J., van Der Bent, C., Papapoulos, S.E., and Lowik, C.W. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143, 1545, 2002.
37. Steinbrech, D.S., Mehrara, B.J., Saadeh, P.B., Greenwald, J.A., Specter, J.A., Gittes, G.K., and Longaker, M.T. VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism. Am J Physiol 278, C853, 2000.
38. Eckardt, H., Ding, M., Lind, M., Hansen, E.S., Christensen, K.S., and Hvid, I. Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. J Bone Joint Surg 87, 1434, 2005.
39. Murphy, W.L., Simmons, C.A., Kaigler, D., and Mooney, D.J. Bone regeneration via a mineral substrate and induced angiogenesis. J Dent Res 83, 204, 2004.
40. Bodde, E.W., Boerman, O.C, Rüssel, F.G., Mikos, A.G., Spauwen, P.H., and Jansen, J.A. The kinetic and biological activity of different loaded rhBMP-2 calcium phosphate cement implants in rats. J Biomed Mater Res A 87, 780, 2008.
41. Chu, T.M., Warden, S.J., Turner, C.H., and Stewart, R.L. Segmental bone regeneration using a load-bearing biodegradable carrier of bone morphogenetic protein-2. Biomaterials 28, 459, 2007.
42. Cowan, C.M., Aghaloo, T., Chou, Y.F., Walder, B., Zhang, X., Soo, C., Ting, K., and Wu, B. MicroCT evaluation of three-dimensional mineralization in response to BMP-2 doses in vitro and in critical sized rat calvarial defects. Tissue Eng 13, 501, 2007.
43. Simmons, C.A., Alsberg, E., Hsiong, S., Kim, W.J., and Mooney, D.J. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 35, 562, 2004.
44. Patel, Z.S., Young, S., Tabata, Y., Jansen, J.A., Wong, M., and Mikos, A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43, 931, 2008.
45. Patel, Z.S., Ueda, H., Yamamoto, M., Tabata, Y., and Mikos, A.G. In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharm Res 25, 2370, 2008.
46. Patel, Z.S., Yamamoto, M., Ueda, H., Tabata, Y., and Mikos, A.G. Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomater 4, 1126, 2008.
47. Holland, T.A., Tessmar, J.K., Tabata, Y., and Mikos, A.G. Transforming growth factor-betal release from oligopoly (ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment. J Control Release 94, 101, 2004.
48. Shung, A.K., Timmer, M.D., Jo, S., Engel, P.S., and Mikos, A.G. Kinetics of poly(propylene fumarate) synthesis by step polymerization of diethyl fumarate and propylene glycol using zinc chloride as a catalyst. J Biomater Sci Polym Ed 13, 95, 2002.
49. Timmer, M.D., Ambrose, C.G., and Mikos, A.G. Evaluation of thermal- and photo-crosslinked biodegradable poly (propylene fumarate)-based networks. J Biomed Mater Res A 66, 811, 2003.
50. Holland, T.A., Tabata, Y., and Mikos, A.G. In vitro release of transforming growth factor-betal from gelatin microparticles encapsulated in biodegradable, injectable oligopoly (ethylene glycol) fumarate) hydrogels. J Control Release 91, 299, 2003.
51. Greenwood, FC, Hunter, W.M., and Glover, J.S. The preparation of I-131-labelled human growth hormone of high specific radioactivity. Biochem J 89, 114, 1963.
52. Feldkamp, L.A., Davis, L.C., and Kress, J.W. Practical conebeam algorithm. J Opt Soc Am A 1, 612, 1984.
53. Hacker, M., Ringhofer, M., Appel, B., Neubauer, M., Vogel, T., Young, S., Mikos, A.G., Blunk, T., Gopferich, A., and Schulz, M.B. Solid lipid templating of macroporous tissue engineering scaffolds. Biomaterials 28, 3497, 2007.
54. van der Lubbe, H.B., Klein, CP., and de Groot, K. A simple method for preparing thin (10 microM) histological sections of undecalcified plastic embedded bone with implants. Stain Technol 63, 171, 1988.
55. Young, S., Wong, M., Tabata, Y., and Mikos, A.G. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 109, 256, 2005.
56. Huang, Z., Nelson, E.R., Smith, R.L., and Goodman, S.B. The sequential expression profiles of growth factors from osteoprogenitors [correction of osteroprogenitors] to osteoblasts in vitro. Tissue Eng 13, 2311, 2007.
57. Lalani, Z., Wong, M., Brey, E.M., Mikos, A.G., and Duke, P.J. Spatial and temporal localization of transforming growth factor-betal, bone morphogenetic protein-2, and plateletderived growth factor-A in healing tooth extraction sockets in a rabbit model. J Oral Maxillofac Surg 61, 1061, 2003.
58. Lalani, Z., Wong, M., Brey, E.M., Mikos, A.G., Duke, P.J., Miller, M.J., Johnston, C., and Montufar-Solis, D. Spatial and temporal localization of FGF-2 and VEGF in healing tooth extraction sockets in a rabbit model. J Oral Maxillofac Surg 63, 1500, 2005.
59. Karageorgiou, V., and Kaplan, D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26, 5474, 2005.
60. Oest, M.E., Dupont, K.M., Kong, H.J., Mooney, D.J., and Guldberg, R.E. Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects. J Orthop Res 25, 941, 2007.
61. Akita, S., Fukui, M., Nakagawa, H., Fujii, T., and Akino, K. Cranial bone defect healing is accelerated by mesenchymal stem cells induced by coadministration of bone morphogenetic protein-2 and basic fibroblast growth factor. Wound Repair Regen 12, 252, 2004.
62. Kakudo, N., Kusumoto, K., Wang, Y.B., Iguchi, Y., and Ogawa, Y. Immunolocalization of vascular endothelial growth factor on intramuscular ectopic osteoinduction by bone morphogenetic protein-2. Life Sci 79, 1847, 2006.
63. Benjamin, L.E., Golijanin, D., Itin, A., Pode, D., and Keshet, E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103, 159, 1999.
64. Peng, H., Wright, V., Usas, A., Gearhart, B., Shen, H.C., Cummins, J., and Huard, J. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110, 751, 2002.